| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/30/2005 | US6936640 uses the strong antimicrobial properties of polymeric biguanides and the low cytotoxicity profile of polymeric quaternary ammonium compounds |
| 08/30/2005 | US6936639 Nitroxyl progenitors in the treatment of heart failure |
| 08/30/2005 | US6936638 for treating or preventing conditions associated with altered mitochondrial function with such compounds eg Alzheimer's Disease; diabetes mellitus; obesity; Parkinson's Disease; Huntington's disease; dystonia; Leber's hereditary optic neuropathy |
| 08/30/2005 | US6936637 In a patient being treated for cancer by administering an an agent that results in the depletion of polyamines within the non-cancerous intestinal cells; e.g., inhibiting ornithine decarboxylase by administering DL-oe-difluoromethylornithine |
| 08/30/2005 | US6936634 Ruthenium (II) compounds for use in the therapy of cancer |
| 08/30/2005 | US6936633 Pyrrolidinone derivatives |
| 08/30/2005 | US6936632 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof |
| 08/30/2005 | US6936631 Bicyclic imidazo-5-yl-amine derivatives |
| 08/30/2005 | US6936630 Sulfur compounds such as 1-(5-chloro-2-methyl-phenyl)-3-(3-methyl-isothiazol-5-yl)-thiourea, used for prophylaxis of cardiovascular disorders |
| 08/30/2005 | US6936628 Orally administering one or more pharmaceutically acceptable acid neutralizing buffers with epothiolones (simultaneously, before or after) to increase the vioavailability of epothiolones |
| 08/30/2005 | US6936627 treating/preventing gastrointestinal disorders, inflammations and microbial infections; improving gastroprotective properties of H2 receptor antagonists; decreasing the recurrence of ulcers; facilitating ulcer healing |
| 08/30/2005 | US6936626 Retinoic acid mimetic anilides |
| 08/30/2005 | US6936625 Amlodipine camsylate and method for preparing thereof |
| 08/30/2005 | US6936623 Pyrano[2,3-C]imidazo[-1,2-A]pyridine derivatives for the treatment of gastrointestinal disorders |
| 08/30/2005 | US6936622 they are phosphodiesterase (PDE) inhibitors useful for treament of allergic rhinitis, crohn's disease, ulcerative colitis, rheumatoid arthritis, bronchitis, bronchial asthma, COPD, ARDS, psoriasis, eczema, and combination thereof thereof. |
| 08/30/2005 | US6936621 Use of benzoylalkyl-1,2,3,6-tetrahydropyridines |
| 08/30/2005 | US6936618 Cystic fibrosis medicaments |
| 08/30/2005 | US6936617 Nitrogen compounds such as 6-chloro-3-ethyl-2-(2-thiazol-2-yl -imidazol-1-ylmethyl)-imidazo(1,2-b)pyridazine used for prophylaxis of nervous system disorders |
| 08/30/2005 | US6936616 Pyrimidine matrix metalloproteinase inhibitors |
| 08/30/2005 | US6936615 Heteroaryl derivatives and their use as medicaments |
| 08/30/2005 | US6936613 for treatment of central nervous system diseases and disorders, which are responsive to modulation of the Gamma amminobutyric acid (GABA) receptor complex, and for inducing and maintaining anesthesia, sedation and muscle relaxation |
| 08/30/2005 | US6936612 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 08/30/2005 | US6936611 Serine protease inhibitors |
| 08/30/2005 | US6936610 Heterocyclic derivatives |
| 08/30/2005 | US6936609 Hydrolase enzyme inhibitors comprising nitrogen compounds such as 2-(3,4-Dimethoxyphenyl)-7-(1-ethylpropyl)-5-methyl-4-(3,4,5-trimethoxyphenoxy)-imidazo[5,1-f][1,2,4]triazine, used for prophylaxis of neurodegenerative disorders |
| 08/30/2005 | US6936608 7-phenylimidazo(1,2-b)(1,2,4)triazine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a |
| 08/30/2005 | US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 08/30/2005 | US6936605 Pharmaceutical composition |
| 08/30/2005 | US6936604 Treating hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema and ischemia, stroke, thrombosis and water retention |
| 08/30/2005 | US6936603 Treating autoimmune diseases mediated by cathepsin S |
| 08/30/2005 | US6936601 Psychological disorders; synergistic mixture |
| 08/30/2005 | US6936600 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents |
| 08/30/2005 | US6936599 Estriol therapy for multiple sclerosis and other autoimmune diseases |
| 08/30/2005 | US6936598 administering fibers selected from oligosaccharides, galactans, glucans and/or mixtures to mammals to reduce Desulfovibrio and/or Helicobacter in the stomachs or intestines, and to deodorize gases and feces; foods |
| 08/30/2005 | US6936597 A conjugate of blocked polymer with a biologically active compound containing reactive hydroxy or amino groups |
| 08/30/2005 | US6936596 Adenosine derivatives and use thereof |
| 08/30/2005 | US6936593 Method of down-regulating gene expression |
| 08/30/2005 | US6936592 antibiotics and antiprotozoa agents |
| 08/30/2005 | US6936590 Treating diabetic with a sodium dependent glucose transporters (SGLT2) inhibitors, especially type II diabetes; use of pyran compounds including dapaglifozin |
| 08/30/2005 | US6936589 Concurrent administering of druh and hypotonic sugar solution |
| 08/30/2005 | US6936588 homogenizing water, fat, a nitrogen-containing component, and carbohydrate with the inclusion of isomaltulose, pasteurizing for 10-30 seconds at 135 degrees c and sterilizing |
| 08/30/2005 | US6936586 interleukin 10 (IL-10) agonists; treatment of pancreatitis, arthritis, gout, allergies, inflammations and ischemias; polypeptides |
| 08/30/2005 | US6936583 coadministering a taxane and an oral bioavailability enhancing agent inhibitor of p-glycoprotein; preventing or reducing hypersensitivity or allergic reactions; anticancer agents |
| 08/30/2005 | US6936458 Isolated DNA comprising one or more genes specific for 5S clavam biosynthesis, vectors comprising such DNA and streptomyces hosts capable of improved clavulanic acid production |
| 08/30/2005 | US6936452 Inhibitors of the inositol polyphosphate 5-phosphate SHIP2 molecule |
| 08/30/2005 | US6936447 Autoinducer molecule |
| 08/30/2005 | US6936435 Compositions and methods for regulating bacterial pathogenesis |
| 08/30/2005 | US6936424 Materials and methods for detection and treatment of breast cancer |
| 08/30/2005 | US6936286 Combination of specific vitamins, minerals, herbs and nutrients. These essential components in the amounts provided uniquely contribute to improved blood sugar levels and insulin delivery to the cells. The formulation contains essential |
| 08/30/2005 | US6936285 Use of Ginkgo biloba extracts for preparing a medicine |
| 08/30/2005 | US6936283 For hangover treatment, comprising caffeine, Guarana, Yerba Mate, Eleutherococcus senticous, Panax ginseng, ginger, Glycyrrhiza glabra, ginkgo biloba and fructose; speeds alcohol and acetaldehyde metabolism |
| 08/30/2005 | US6936280 Method for preparing a composition by extraction of mother-of-pearl, composition obtained by said method and use thereof in cosmetics and dermatology |
| 08/30/2005 | US6936279 Microcrystalline zeaxanthin with high bioavailability in oily carrier formulations |
| 08/30/2005 | US6936274 Storage stable thyroxine active drug formulations and methods for their production |
| 08/30/2005 | US6936273 Treating lameness in horses with a topical nonsteroidal antiinflammatory formulation of diclofenac salt, propylene glycol, ethanol, vitamin E acetate, phospholipid, wherein vesicles or liposomes of the diclofenac salt are present |
| 08/30/2005 | US6936270 Orthopedic hardware with a sustained release device configured to release a compound over an extended period of time and is attachable to a portion of the body |
| 08/30/2005 | US6936267 Anti-acne compositions and methods of use |
| 08/30/2005 | US6936266 Desquamation/epidermal renewal of the skin and/or combating skin aging |
| 08/30/2005 | US6936261 Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis |
| 08/30/2005 | US6936253 Ganglioside-KLH conjugate vaccines plus QS-21 |
| 08/30/2005 | US6935334 Enhancing therapeutic effectiveness of nitric oxide inhalation |
| 08/30/2005 | CA2336968C Quinoline derivatives |
| 08/30/2005 | CA2213774C Pharmaceutical compositions and devices for their administration |
| 08/30/2005 | CA2211262C Micellar nanoparticles |
| 08/30/2005 | CA2202879C Calcium receptor-active compounds |
| 08/30/2005 | CA2195372C A method of preparing the enantiomers of o-demethyltramadol |
| 08/30/2005 | CA2164060C Lactate dehydrogenase inhibitors in cosmetic compositions |
| 08/30/2005 | CA2133152C Piperidines and piperazines with affinity for 5-ht receptors |
| 08/30/2005 | CA2103667C Liquid compositions based on 1,4 substituted piperidine derivatives |
| 08/27/2005 | CA2491203A1 Topical antibacterial formulations |
| 08/25/2005 | WO2005078125A2 Itpase gene polymorphisms associated with adverse drug reactions to azathioprine therapy |
| 08/25/2005 | WO2005078093A1 siRNA MOLECULE INHIBITING THE EXPRESSION OF PRION GENE |
| 08/25/2005 | WO2005078090A2 Antisense oligonucleotides for treating unwanted pigmentation of the skin and hair |
| 08/25/2005 | WO2005078084A1 Polyion complex carrying double stranded oligonucleic acid, process for producing the same and pharmaceutical composition containing the same |
| 08/25/2005 | WO2005078081A1 Use of compounds that regulate hdac6 tubulin deacetylase activity in the preparation of pharmaceutical compositions, method of identifying the aforementioned regulating compounds, said pharmaceutical compounds and applications thereof |
| 08/25/2005 | WO2005078016A1 Room temperature stable agarose solutions |
| 08/25/2005 | WO2005077968A2 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity |
| 08/25/2005 | WO2005077964A1 Derivatives of saccharides and itols having an o-n- alcanoyl group and an o-ortho-acetylsalicyloyl group, uses thereof as food additives or non-food additives or as medicaments |
| 08/25/2005 | WO2005077963A1 Saccharide and itol derivatives having an o-alkyl group or an o-alkyl group and an o-n butanyl group, uses as medicines in tumoral or benign proliferative pathologies |
| 08/25/2005 | WO2005077959A1 Pth agonists |
| 08/25/2005 | WO2005077954A2 Pyrazolopyrimidine-derivatives as cyclin dependent kinase inhibitors |
| 08/25/2005 | WO2005077949A1 Tricyclic imidazopyridines and intermediates for the synthesis thereof |
| 08/25/2005 | WO2005077948A1 Fungicidal heterocyclic compounds |
| 08/25/2005 | WO2005077941A2 Candesartan cilexetil polymorphs |
| 08/25/2005 | WO2005077940A1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 08/25/2005 | WO2005077938A1 Vanilloid receptor ligands and their use in treatments |
| 08/25/2005 | WO2005077936A1 Pyridine benzimidazole sulfoxides with high purity |
| 08/25/2005 | WO2005077934A1 Anthranilamides, process for the production thereof, and pest controllers containing the same |
| 08/25/2005 | WO2005077933A1 Novel polymorphic form of imatinib mesylate and a process for its preparation |
| 08/25/2005 | WO2005077932A2 Chemokine receptor antagonists |
| 08/25/2005 | WO2005077925A1 Sulfonylpyrrolodine modulators of androgen receptor fuction and method |
| 08/25/2005 | WO2005077920A1 Quinoxaline compounds and methods of using them |
| 08/25/2005 | WO2005077918A1 Pth agonists |
| 08/25/2005 | WO2005077915A1 Pyridazinones as antagonists of a4 integrins |
| 08/25/2005 | WO2005077914A1 PYRIDAZINONE UREAS AS ANTAGONISTS OF α4 INTEGRINS |
| 08/25/2005 | WO2005077912A1 Indazole compound and pharmaceutical use thereof |
| 08/25/2005 | WO2005077910A1 Pyrazoline derivatives useful for the treatment of cancer |
| 08/25/2005 | WO2005077905A1 Fused-ring 4-oxopyrimidine derivative |
| 08/25/2005 | WO2005077902A2 Methods for the synthesis of pyridoxamine |
| 08/25/2005 | WO2005077900A1 Bicyclic amide derivatives |